Phil Nichols
Pharmaceuticals
Propharma Partners
Japan
Biography
Phil Nichols is a physician by training (BMedSci, MBBS Newcastle 1991) and continues to practice one day per week as a Consultant Neurologist for the NHS (Royal Victoria Infirmary, Newcastle). He is a Fellow of the Royal College of Physicians (UK) and a member of the Association of British Neurologists. He has a postgraduate PhD qualification in Medicine (MRC Clinical Research Fellowship, DPhil, St. John’s College, Oxford) and won a Department of Health Clinician Scientist Award studying the mechanisms underlying chronic multiple sclerosis from 2002-’07. He continues to hold a part time academic Senior Lecturer position at Newcastle University. From 2005-’09 he held the position of Chief Medical Officer and Head of Clinical Development at Cambridge Laboratories (Ireland) Ltd, a UK & Ireland based entrepreneurial pharmaceutical company specializing in CNS and oncology products. He had overall responsibility for pre-clinical and clinical phases of drug development and was a member of the value realization team negotiating the recent sale of a major pharmaceutical asset (Tetrabenazine, Xenazine/Nitoman) for $230 million to BIOVAIL in 2009.
Research Interest
..
